2010 National Immunization Survey Results - Vaccination Coverage Levels
The NIS and NIS-Teen are conducted by the Centers for Disease Control and Prevention to assess the vaccination coverage level among children 19 through 35 months of age and adolescents 13 through 17 years of age. NIS and NIS-Teen utilize a random digit dial survey to collect immunization information from households with eligible participants. For completeness and verification, immunization data are also requested from vaccination providers with consent of parents.
Children 19-35 Months of Age
Results for the 2010 NIS conducted from January through December of 2010 showed that the 4-3-1-3-3-1-4 (four or more doses of Diphtheria-Tetanus-Pertussis vaccine, three or more doses of Poliovirus vaccine, one or more doses of any Measles-containing vaccine, three or more doses of Haemophilus influenzae type b vaccine, three or more doses of Hepatitis B, one or more doses of Varicella, and 4 or more doses of pneumococcal) vaccination coverage level for children aged 19 through 35 months in the state of Texas was 70.1(±4.1). The Hib shortage that occurred from December 2007 to September 2009, temporary suspension of the Hib booster dose at 12-15 months, and a new method for measuring Hib coverage had a major effect on coverage estimates in most states in 2010 compared to 2009.
State Coverage Estimates in the 2010 NIS are Based on the Series that Excludes Hib, 4-3-1-0-3-1-4
Results for the 2010 NIS showed that the 4-3-1-0-3-1-4 (four or more doses of Diphtheria-Tetanus-Pertussis vaccine, three or more doses of Poliovirus vaccine, one or more doses of any Measles-containing vaccine, zero doses of Haemophilus influenzae type b vaccine, three or more doses of Hepatitis B, one or more doses of Varicella, and 4 or more doses of pneumococcal) vaccination coverage level for children age 19 through 35 months in the state of Texas was 70.9 (±4.1). The survey assessed the immunization histories of approximately 1,379 children in Texas aged 19 through 35 months. These children were born between January 2007 and July 2009.
4-3-1-0-3-1-4 Series1 Estimated Coverage among Children 19-35 Months of Age
| Geographic Area | Coverage (95% CI) |
|---|---|
| Bexar County | 73.7% (±6.5) |
| Dallas County | 69.3% (±6.8) |
| El Paso County | 67.0% (±7.2) |
| Houston, City of | 73.2% (±6.1) |
| Texas (entire state) | 70.9% (±4.1) |
1 Four or more doses of Diphtheria-Tetanus-Pertussis vaccine, three or more doses of Poliovirus vaccine, one or more doses of any Measles-containing vaccine, zero doses of Haemophilus influenzae type b vaccine, three or more doses of Hepatitis B, one or more doses of Varicella, and 4 or more doses of pneumococcal.
Individual Vaccine Coverage Levels for Children 19-35 Months of Age
| Vaccine | Coverage (95% CI) |
|---|---|
| DTAP, 4 doses | 83.9% (±3.3) |
| Haemophilus Influenzae Type B, 3 doses | 90.6% (±2.6) |
| Hepatitis B, 3 doses | 88.4% (±2.7) |
| Measles, 1 dose | 91.8% (±2.4) |
| Pneumococcal, 4 doses | 83.0% (±3.3) |
| Polio, 3 doses | 91.9% (±2.1) |
| Varicella, 1 dose | 90.2% (±2.5) |
Adolescents 13-17 years
The 2010 NIS-Teen survey assessed the immunization histories 19,257 adolescents (10,037 males and 9,220 females) adolescents in the US aged 13 to 17 years of age. These adolescents were born between January 1992 and February 1998.
Individual Vaccine Coverage Levels for Children 13-17 Years of Age
| Vaccine | Bexar County (95% CI) | Dallas County (95% CI) | El Paso County (95% CI) | Houston, City of (95% CI) | State of Texas (95% CI) |
|---|---|---|---|---|---|
| Hepatitis B, 3 doses |
88.7% (84.4% - 91.9%) |
83.2% (75.9% - 88.6%) |
91.1% (87.1% - 93.9%) |
83.4% (77.7% - 87.8%) |
87.2% (83.5% - 90.1%) |
| HPV, 1 dose |
44.2% (36.4% - 52.2%) |
34.4% (24.6% - 45.7%) |
67.4% (58.8% - 74.9%) |
55.1% (46.2% - 63.8%) |
47.5% (40.5% - 54.6%) |
| MCV4, 1 dose |
72.0% (66.3% - 77.1%) |
72.9% (65.5% - 79.3%) |
80.8% (75.8% - 85.0%) |
75.9% (69.9% - 81.0%) |
65.4% (60.5% - 70.0%) |
| MMR, 2 doses |
85.6% (80.9% - 89.2%) |
81.4% (73.9% - 87.0%) |
87.5% (82.7% - 91.1%) |
82.3% (76.7% - 86.8%) |
84.3% (80.4% - 87.5%) |
| Td or Tdap, 1 dose |
86.1% (81.4% - 89.8%) |
80.6% (73.5% - 86.2%) |
87.9% (83.4% - 91.3%) |
82.1% (76.7% - 86.5%) |
83.2% (79.3% - 86.4%) |
| Tdap, 1 dose |
72.1% (66.5% - 77.0%) |
72.5% (65.2% - 78.7%) |
79.5% (74.2% - 83.9%) |
71.3% (65.2% - 76.7%) |
71.9% (67.4% - 76.0%) |
| Varicella, 1 dose |
93.3% (88.9% - 96.0%) |
93.7% (88.9% - 96.5%) |
94.4% (89.4% - 97.1%) |
91.2% (84.7% - 95.1%) |
92.2% (88.0% - 95.0%) |
Source: